首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD3E Recombinant Antibody(Visilizumab)

Anti-Human CD3E Recombinant Antibody(Visilizumab)

产品编号

YR1046

别名

科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab
Catalog NumberYR1046
Molecular NameVisilizumab
CAS Number219716-33-3
TargetCD3E[Homo sapiens]
Antibody IsotypeIgG2
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundVisilizumab (tentative trade name Nuvion, PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease. Visilizumab binds to the CD3 receptor on certain activated T cells without affecting resting T cells. It is currently under clinical studies for the treatment of ulcerative colitis and Crohn's disease.
ApplicationELISA, IHC, IF, IP, FCM, FuncS
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价